A paper using https://t.co/OyyJrBp0TH (from @activemotif) was just published in Cancer Research, see "An AIB1 isoform alters enhancer access and enables…": https://t.co/0xEGcGRIY4 (https://t.co/kbaoZl27cs). Thank you for making your #methodsmatter. #accele
Apsra Nasir, Garrett Graham, Max Kushner, and @willbekietz are co-authors on a publication in Cancer Research on regulation of triple negative breast cancer progression by the #nuclearreceptor coregulator AIB1 4/n https://t.co/er2ZRq7kTn
An AIB1 Isoform Alters Enhancer Access and Enables Progression of Early-Stage Triple-Negative #BreastCancer. #TNBC https://t.co/ztIxfvkMVx
RT @MorayCampbell: Great to see this paper come out resulting from a fantastic collaboration with Dr. Anne Riegel and group @Georgetown.…
An AIB1 Isoform Alters Enhancer Access and Enables Progression of Early-Stage Triple-Negative Breast Cancer https://t.co/MOaNm0Idp8 https://t.co/oEz7QEhkY6
An AIB1 Isoform Alters Enhancer Access and Enables Progression of Early-Stage Triple-Negative Breast Cancer https://t.co/eVhlymgBEM https://t.co/drlRei1bUT
An AIB1 Isoform Alters Enhancer Access and Enables Progression of Early-Stage Triple-Negative Breast Cancer https://t.co/ium3mHBEVA
RT @MorayCampbell: Great to see this paper come out resulting from a fantastic collaboration with Dr. Anne Riegel and group @Georgetown.…
RT @MorayCampbell: Great to see this paper come out resulting from a fantastic collaboration with Dr. Anne Riegel and group @Georgetown.…
Great to see this paper come out resulting from a fantastic collaboration with Dr. Anne Riegel and group @Georgetown. Isoforms of a coregulater change enhancer access in triple-negative breast cancer. @osu_pharmacy @OSUCCC_James https://t.co/VAGkRzqa
Led by Drs. Anna Riegel and Ghada Sharif, researchers from @Georgetown and @OhioState used #CRISPR to produce breast epithelial cells that expressed an AIB1 isoform, which were used to study the isoform's role in ductal #carcinoma malignancy. 🙌 📙 https:/
An AIB1 isoform alters enhancer access and enables progression of early stage triple-negative breast cancer https://t.co/3VAEgefv7i
An AIB1 isoform alters enhancer access and enables progression of early stage triple-negative breast cancer https://t.co/NzS9OrXfV7
An AIB1 isoform alters enhancer access and enables progression of early stage triple-negative breast cancer https://t.co/Bbm75DSDzP
New article: An AIB1 isoform alters enhancer access and enables progression of early stage triple-negative breast cancer https://t.co/3C1Tj3NkKL #lungcancer #oncology https://t.co/OKMGL0f6Dr